Curebase, a decentralized clinical trials platform, announced a $15 million Series A funding round.
The financing round was led by GGV Capital with Xfund, Bold Capital, and several other institutional funds, bringing the total raised to $19 million.
As part of the funding, Jeff Richards, managing partner, GGV Capital, will join the company’s board of directors. “At GGV we look for companies that are redefining massive categories by building ambitious, ground-up software platforms. The $50B clinical trial industry is clearly about to transform itself, and Curebase has a clear vision to reinvent the entire ecosystem to reach any patient, anywhere,” said Jeff Richard.
With this latest round of funding, Curebase plans to accelerate its decentralized clinical research software platform and expand its market presence.
The investment will further the company’s technology in real-world medical data in clinical research, home care, telemedicine, and clinical research as care option methods that utilize physicians, labs, pharmacies, and other real-world healthcare touchpoints.
According to Curebase, the platform enables any patient and any healthcare provider to be part of a clinical study, accelerating enrollment and enabling novel study designs with diverse populations. Curebase operates as a complete eClinical software platform and virtual research site with features including digital recruitment, ePRO, eCOA, telemedicine, eConsent, eSource, and more.
“We are currently running clinical trial designs that most researchers think won’t be possible for another five years. This is research where any patient can sign up at home and collect data whenever they go to their own doctor. We’re doing it in women’s health, cancer diagnostics, GI, and many other areas,” said Tom Lemberg, founder, and CEO, Curebase.
Tom Lemberg added: “Our software and our novel virtual site framework is already combining elements of home-based research, telemedicine research, real-world data, and clinical research as a care option in ways that would surprise a lot of clinical operations leaders in the industry.”
Digital health companies raised $7.2 billion in Q1 2021, according to Mercom’s Q1 2021 Digital Health Funding and M&A Report.
